video corpo

Anesthesia syringe pump MS39
1-channeltCIwith touch screen

anesthesia syringe pump
anesthesia syringe pump
anesthesia syringe pump
anesthesia syringe pump
anesthesia syringe pump
Add to favorites
Compare this product
 

Characteristics

Applications
anesthesia
Number of channels
1-channel
Operational mode
tCI
Other characteristics
with touch screen

Description

Manual and Auto-integrated push handle: intelligent sense of syringe push handle position, automatically eliminate sensor clearance, fast start infusion. Target Control Mode Plasma target control mode, effect chamber target control mode. It can quickly and accurately adjust the blood concentration and maintain the stability of anesthesia. Target Controlled Drugs and Models Support propofol, sufentanil, remifentanil and a variety of common anesthetics. Multiple pharmacokinetic models, including Propofol Eleveld model, pediatric model. Trend View Support graphical statistics and prediction of blood drug concentration. Intelligently adjust the target blood concentration and easily control the depth of anesthesia. Wake Up Time The wake-up time is predictable, with an error of less than 10%. Precise Algorithm , More Secure • The volume tolerance between the simulated curves of each pharmacokinetic model and the actual operation curves is less than 2%. Six kinds of drugs, Eleven TCI Models • Based on the pharmacokinetic model (PK model), it supports all main anaesthetic and TCI models on the market. • The MS series TCI pump support total 12 different infusion mode like sequence, loading dose, body weight and etc., which can quickly achieve the required stable blood concentration for patients.

Catalogs

No catalogs are available for this product.

See all of Lianying Medical Technology‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.